Uniunea Europeană - română - EMA (European Medicines Agency)

takeda pharma a/s - brentuximab vedotin - lymphoma, non-hodgkin; hodgkin disease - agenți antineoplazici - hodgkin lymphomaadcetris is indicated for adult patients with previously untreated cd30+ stage iv hodgkin lymphoma (hl) in combination with doxorubicin, vinblastine and dacarbazine (avd). adcetris is indicated for the treatment of adult patients with cd30+ hl at increased risk of relapse or progression following autologous stem cell transplant (asct). adcetris is indicated for the treatment of adult patients with relapsed or refractory cd30+ hodgkin lymphoma (hl):following asct, orfollowing at least two prior therapies when asct or multi-agent chemotherapy is not a treatment option. systemic anaplastic large cell lymphomaadcetris in combination with cyclophosphamide, doxorubicin and prednisone (chp) is indicated for adult patients with previously untreated systemic anaplastic large cell lymphoma (salcl). adcetris is indicated for the treatment of adult patients with relapsed or refractory salcl. cutaneous t cell lymphomaadcetris is indicated for the treatment of adult patients with cd30+ cutaneous t cell lymphoma (ctcl) after at least 1 prior systemic therapy.

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 10mg/160mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 10mg/160mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 10mg/320mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 5mg/160mg/12,5mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

krka d.d., novo mesto - slovenia - combinatii (amlodipina+valsartan+hct) - compr. film. - 5mg/160mg/25mg - antagonisti ai angiotensinaei ii, combinatii antagonisti ai angiotensinaei ii, combinatii

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glenmark pharmaceuticals s.r.o. - republica ceha - combinatii (olopatadinum+mometasonum) - spray naz.,sol. - 25micrograme/600micrograme/doza - decongestionante si alte medicamente nazale de uz topic corticosteroidiene

Republica Moldova - română - AMDM (Agenţia Medicamentului şi Dispozitivelor Medicale)

glenmark specialty s.a. - olopatadinum + mometasonum furoatum - spray nazal, suspensie - 600 mcg/25 mcg/doză

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

takeda italia spa - italia - brentuximab vedotin - pulb. pt. conc. pt. sol. perf. - 50 mg - alte antineoplazice anticorpi monoclonali

România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

stallergenes s.a. - franta - extract alergenic standardizat - susp. inj. - 0,1ir/ml - alergeni alergeni - extracte